Supports Earnings

• Illumina shares continued to rise recently as an earnings recovery helped the company and the broader biotech sector outperform the market. • The stock rally follows a period of regulatory and market challenges that previously hindered the company's growth. • This recovery suggests a shift in investor confidence toward biotech stocks after a period of volatility.

• DNB, Norway's largest bank, is seeing steady stock performance driven by strong earnings and increased net interest income. • The bank maintains solid capital ratios and liquidity, reinforcing its stability and dominant position within the Nordic financial sector. • This financial flexibility allows for strategic investments and risk management, which are expected to shape the company's medium-term earnings narrative.

• Raymond James stock is trading steadily following quarterly results that revealed higher revenue and strong client asset flows. • Growth is primarily driven by the company's diversified business model, specifically its Private Client Group, Capital Markets, Asset Management, and RJ Bank segments. • The firm is balancing disciplined capital returns with the need to retain earnings to support balance-sheet growth in lending and interest-earning activities.